Le Lézard
Classified in: Health
Subjects: NPT, AVO

Briefing on Capitol Hill Urges More Government Action and Investment in the Epilepsies


WASHINGTON, May 24, 2023 /PRNewswire/ -- In cooperation with the Congressional Epilepsy Caucus, organizations including the Epilepsy Foundation, Epilepsies Action Network, CURE Epilepsy, Rare Epilepsy Network and DEE-P Connections hosted a briefing on Capitol Hill on May 17 to educate about the epilepsies and call for more government action and investment in the epilepsies. Congressional Epilepsy Caucus co-chairs Congressman Greg Murphy, M.D. (R-NC-3) and Jim Costa (D-CA-21) spoke about their personal connections to epilepsy and the importance of the caucus.

"My son developed epilepsy when he was 14 and it took us months to get the right treatment for him," said Congressman Murphy. "While he is now 28 and his seizures are controlled, there are still millions of Americans who continue to struggle with seizures. My sister is one of those people. I am committed to elevating the community's voice in Washington to bring much-needed education and awareness about this very common yet stigmatized neurological condition."

The community spoke with one voice, delivering a letter to Capitol Hill urging Congress to support the following epilepsy programs and research in the federal Fiscal Year (FY) 2024 budget:

"Epilepsy is a neurological condition that has been with us for a long time. We probably all know someone with epilepsy," said Congressman Costa. "It's critical that those living with epilepsy have a voice in Congress that advocates for their needs and supports funding for epilepsy research. I'm committed to working together with our colleagues in a bipartisan manner to improve access to care for all Americans with the epilepsies."

The briefing, which was moderated by Laura Lubbers, PhD, Chief Scientific Officer, CURE Epilepsy, also included a mother who lost her 21-year-old son to SUDEP; a mother who cares for her 10-year-old son who functions at the level of a 2-month old due to his rare, genetic and severe epilepsy SCN8A; and a college student who is thriving despite her seizures and has overcome the stigma that comes with living with epilepsy. Together, the speakers explained how profoundly and differently epilepsy impacts people and families and why increased funding from Congress can help close gaps in care. The annual total healthcare burden for people living with the epilepsies and/or seizures is at least $54 billion.

"Epilepsy is considered a spectrum disorder with different causes and seizure types," said Dr. Archana Pasupuleti, pediatric neurology specialist at Children's National Hospital. "While we continue to make progress to understand the underlying causes of epilepsy, we still have 50% of patients for whom we don't know the cause and at least 30% for whom treatment is ineffective. This is where funding for research and surveillance can really make a difference in how we treat epilepsy with the goal of helping to improve the quality of life for those living with it." 

About Epilepsy
According to the World Health Organization, epilepsy is the most common serious brain disorder worldwide, with no age, racial, social class, national or geographic boundaries. The U.S. Centers for Disease Control & Prevention (CDC) estimates that 3.4 million people in the United States are affected by epilepsy, or approximately 1 in 26 people. Epilepsy is the underlying tendency of the brain to produce seizures, which are sudden abnormal bursts of electrical energy that disrupt brain functions. In addition to those diagnosed with epilepsy, one in ten people will have a single seizure in their lifetime. The annual total healthcare burden for people living with the epilepsies and/or seizures is at least $54 billion.

About Epilepsies Action Network
With the mission of advancing strategic national policies, innovative research programs, and funding to improve the lives and outcomes of ALL those living and struggling with the epilepsies, the Epilepsies Action Network was initiated in August 2022. It includes dozens of epilepsy organizations that are partners and a National Advisory Board with national experts in the epilepsies, as well as healthcare thought leaders including Dr. Chris Austin, Former founding Director of the National Center for Advancing Translational Sciences (NCATS); Dr. Howard Koh, Former Assistant Secretary for Health for the U.S. Department of Health and Human Services (2009-2014); Tony Coelho, Former United States Congressman from California and Primary Author and Sponsor of the Americans with Disabilities Act; and Greg Grunberg, actor and advocate. Follow us on LinkedIn.

About the Epilepsy Foundation
With a network of partners throughout the United States, the Epilepsy Foundation is leading the fight to overcome the challenges of living with epilepsy. The Foundation connects people to treatment, support, and resources; leads advocacy efforts; funds innovative research and the training of specialists; and educates the public about epilepsy and seizure first aid. For more than five decades, the Epilepsy Foundation has shone a light on epilepsy to promote awareness and understanding, and to advocate for laws that matter to people with epilepsy, while also funding epilepsy research and supporting epilepsy investigators and specialists in their early careers. In partnership with the CDC, the Epilepsy Foundation has helped to improve access to care for people with epilepsy, expanded its digital reach and online resources in homes across the country, and trained more than 600,000 people in seizure recognition and first aid. The Epilepsy Foundation has also assisted more than 140,000 people through its 24/7 Helpline, and continues to focus on innovation, new therapies, community services, advocacy and education as key priorities. To learn more visit epilepsy.com or call 1.800.332.1000. Follow us on FacebookTwitter, Instagram, LinkedIn, TikTok and YouTube

SOURCE Epilepsy Foundation


These press releases may also interest you

2 mai 2024
The report titled "Muscle Stimulator Market by Technique (Burst Mode Alternating Current, Functional Electrical Stimulation, Interferential), Modality (Handheld, Portable, Table Top), Area, Application, End-User - Global Forecast 2024-2030" is now...

2 mai 2024
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announce that they have...

2 mai 2024
The United States of America and ReNew Health Group LLC have settled a nursing home whistleblower claim involving allegations that the nursing home chain submitted false Medicare claims. We need transparency and accountability in our nursing homes....

2 mai 2024
The 5p- Society of North America, along with families and support organizations from over 95 countries, are bringing awareness of 5p Deletion Syndrome also known as 5p Minus (5p-)...

2 mai 2024
Alleva, a leading provider of electronic medical record (EMR) solutions, attended the first-ever East Coast TCIV conference last week in Palm Beach, Florida. The company's CEO, Steve McCall, Director of Sales, John David, and Manager of Strategic...

2 mai 2024
The Canadian Food Inspection Agency (CFIA) has confirmed the presence of emerald ash borer (EAB - Agrilus planipennis) in the City of Vancouver, British Columbia. These detections, which are outside of currently regulated areas for emerald ash borer...



News published on and distributed by: